Wave Life Sciences (WVE) Accumulated Depreciation & Amortization: 2015-2024
- Wave Life Sciences' Accumulated Depreciation & Amortization rose 8.48% to $46.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $159.1 million, marking a year-over-year increase of 15.57%. This contributed to the annual value of $46.3 million for FY2024, which is 8.48% up from last year.
- Wave Life Sciences' Accumulated Depreciation & Amortization amounted to $46.3 million in Q4 2024, which was up 8.48% from $42.7 million recorded in Q4 2023.
- In the past 5 years, Wave Life Sciences' Accumulated Depreciation & Amortization registered a high of $46.3 million during Q4 2024, and its lowest value of $24.9 million during Q4 2020.
- Over the past 3 years, Wave Life Sciences' median Accumulated Depreciation & Amortization value was $42.7 million (recorded in 2023), while the average stood at $42.3 million.
- Data for Wave Life Sciences' Accumulated Depreciation & Amortization shows a peak YoY skyrocketed of 46.41% (in 2020) over the last 5 years.
- Over the past 5 years, Wave Life Sciences' Accumulated Depreciation & Amortization (Quarterly) stood at $24.9 million in 2020, then climbed by 29.47% to $32.2 million in 2021, then grew by 17.42% to $37.8 million in 2022, then climbed by 12.85% to $42.7 million in 2023, then climbed by 8.48% to $46.3 million in 2024.
- Its last three reported values are $46.3 million in Q4 2024, $42.7 million for Q4 2023, and $37.8 million during Q4 2022.
